MARKETING RATIONALE FOR THE EXPEDIENCY OF THE DEVELOPMENT OF A NEW PLANT-BASED MEDICINAL PREPARATION FOR TYPE TWO DIABETES MELLITUS TREATMENT
DOI:
https://doi.org/10.11603/2312-0967.2017.3.8030Keywords:
marketing research, type two diabetes mellitus, oral hypoglycemic drugs, pharmaceutical market of Ukraine.Abstract
The aim of the work. Rationalizing in the context of marketing the expediency of the development of a new plant-based medicinal preparation for type two diabetes mellitus treatment.
Materials and Methods. The marketing method, methods of monitoring, logical generalization, grouping and graphical method of investigation were used in this work.
Results and Discussion. A comparative analysis of the assortment and economic availability of oral hypoglycemic drugs of synthetic and vegetable origin presented on the pharmaceutical market ofUkraine has been conducted. It has been found that among synthetic drugs biguanides and sulfonylureas are characterized by the broadest assortment and economic availability. Compared with synthetic drugs, plant-based medicines are more affordable, but their assortment is very limited.
Conclusions. According to the results of the research which has been carried out the prospects for the development of a new domestic plant-based medicinal preparation in a solid dosage form for type two diabetes mellitus treatment are rationalized.References
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(Suppl.1):62–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797383/pdf/zdcS62.pdf. DOI: 10.1155/2015/340838. [Accessed March 2017].
International Diabetes Federation. IDF Diabetes Atlas, 7th edn. [Electronic resource]. Brussels, Belgium: International Diabetes Federation, 2015. Available from: https://www.idf.org/e-library/epidemiology-research/diabetes-atlas.html. [Accessed March 2017].
Center for Health Statistics Ministry of Health of Ukraine. Ukrainian Medical and Statistical Information Base [Electronic resource, Ukrainian]. Available from: http://medstat.gov.ua/ukr/news.html. [Accessed March 2017].
Wilcox G. Insulin and insulin resistance. Clin Biochem Rev. 2005;26(2):19-39.
Bolen S, Feldman L, Vassy J, Wilson L, Yeh HC, Marinopoulos S, et al. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med. 2007;147(6):386-99.
Bennett WL, Maruthur NM, Singh S, Segal JB, Wilson LM., Chatterjee R, et al. Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med. 2011;154(9):602-13. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733115/pdf/nihms484311.pdf. DOI: 10.7326/0003-4819-154-9-201105030-00336. [Accessed March 2017].
Pankiv VI. [Safety and clinical efficiency of using combined preparation of metformin extended-release and glimepiride]. Mizhnar endokryn zhurnal. 2013;3:25-9. Ukrainian.
Tiwari P. Recent Trends in Therapeutic Approaches for Diabetes Management: A Comprehensive Update. J Diabetes Res. 2015. Available from: https://www.hindawi.com/journals/jdr/2015/340838. DOI: 10.1155/2015/340838 [Accessed March 2017].
Prabhakar PK, Doble M. Synergistic effect of phytochemicals in combination with hypoglycemic drugs on glucose uptake in myotubes. Phytomedicine. 2009;16(12):1119-26. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19660925. DOI: 10.1016/j.phymed.2009.05.021. [Accessed March 2017].
The State Register of Medicinal Products of Ukraine [Electronic resource, Ukrainian]. Available from: http://www.drlz.kiev.ua. [Accessed March 2017].
Compendium. Medicinal Preparations [Electronic resource, Russian]. Available from: http://compendium.com.ua. [Accessed March 2017].
GeoApteka [Electronic resource, Russian]. Available from: https://geoapteka.com.ua. [Accessed March 2017].
Tabletki.ua [Electronic resource, Russian]. Available from: https://tabletki.ua. [Accessed March 2017].
Program complex "Apteka". Wholesale offers [Electronic resource, Russian]. Available from: http://pharmbase.com.ua/poisk1. [Accessed March 2017].
WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2017 [Electronic resource]. Available from: https://www.whocc.no/atc_ddd_index. [Accessed March 2017].
Demidova MA, Novitskaya AR. [Comparative pharmacoeconomic study of using transdermal forms of estradiol and progesterone for intravaginal introduction (utrogestan) in the treatment of women with climacteric syndrome]. Verkhnevolzhskiy med zhurn. 2013;1:30-4. Russian.
State Statistics Service of Ukraine [Electronic resource, Ukrainian]. Available from: http://www.ukrstat.gov.ua. [Accessed March 2017].
Downloads
Published
How to Cite
Issue
Section
License
The authors who publish their materials in this journal agree with the following terms:
- Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal
. - Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.
Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).
